Literature DB >> 10568571

Impact of sex on inheritance of ankylosing spondylitis: a cohort study.

A Calin1, S Brophy, D Blake.   

Abstract

BACKGROUND: Ankylosing spondylitis is a genetically determined and commonly familial disorder. Men and women differ in their susceptibility to ankylosing spondylitis, with about 2.5 men affected for every woman with the disease. We investigated the influence of the sex of the index case on disease penetrance within families.
METHODS: The ages at which 50% and 75% of patients were diagnosed with ankylosing spondylitis were ascertained from a database of 4400 cases. Index patients with children or siblings who were old enough to have obtained a diagnosis (50% and 75% rates) were assessed for prevalence of disease among relatives. Confirmation of diagnosis for affected relatives was sought for all offspring and a random 25% selection of siblings.
FINDINGS: Ankylosing spondylitis was more prevalent among children (odds ratio 1.9 [95% CI 1.2-3.0], p<0.005) and siblings (1.5 [1.2-1.9], p<0.0001) of female index cases than among those of male cases. Analyses restricted to index cases with a young age at onset (< or = 21 years) indicated that children of women had an even higher incidence of ankylosing spondylitis (7.2 [1.5-34], p=0.013) than did children of men at similar age at onset. 38% of children of female cases had disease compared with 8% of male cases. There was no difference in sex distribution among affected children or siblings of female patients with ankylosing spondylitis. By contrast, the sons and brothers of male patients had a higher prevalence of the disease (odds ratio 2.6 [1.4-5.2], p=0.003) than did daughters and sisters (1.7 [1.3-2.2], p<0.0001).
INTERPRETATION: The influence of female sex is greater than that of male sex in determining increased susceptibility to ankylosing spondylitis in children. The striking maternal effect is greatest for women with young age at onset, which is not seen in men. The sex ratio of affected children depends on the sex of the affected parent.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568571     DOI: 10.1016/S0140-6736(99)03219-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  23 in total

1.  Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis.

Authors:  M A Brown; S H Laval; S Brophy; A Calin
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 2.  Genetics of ankylosing spondylitis: an update.

Authors:  Proton Rahman
Journal:  Curr Rheumatol Rep       Date:  2007-10       Impact factor: 4.592

Review 3.  Clinical observations programme in SpA: disease parameters, treatment options and practical management issues.

Authors:  Dirk Elewaut; Filip Van den Bosch; Gust Verbruggen; Filip de Keyser; Bert Vander Cruyssen; Herman Mielants
Journal:  Rheumatol Int       Date:  2008-09-26       Impact factor: 2.631

Review 4.  Predisposing factors in the spondyloarthropathies: new insights into the role of HLA-B27.

Authors:  R A Colbert; S Prahalad
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

5.  Effects of Tripterygium glycosides on interleukin-17 and CD4+CD25+CD127low regulatory T-cell expression in the peripheral blood of patients with ankylosing spondylitis.

Authors:  Wei Ji; Honggang Li; Feng Gao; Yajun Chen; Lingyu Zhong; Dan Wang
Journal:  Biomed Rep       Date:  2014-03-24

6.  Two distinct patterns of ankylosing spondylitis in Moroccan patients.

Authors:  Laila El Mansouri; Rachid Bahiri; Fatima Ezzahra Abourazzak; Radouan Abouqal; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2009-03-04       Impact factor: 2.631

7.  Genetic polymorphisms of stromal interaction molecule 1 associated with the erythrocyte sedimentation rate and C-reactive protein in HLA-B27 positive ankylosing spondylitis patients.

Authors:  James Cheng-Chung Wei; Kuo-Sheng Hung; Yu-Wen Hsu; Ruey-Hong Wong; Chun-Huang Huang; Ming-Shiou Jan; Shyh-Jong Wu; Yung-Shun Juan; Wei-Chiao Chang
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

8.  Protocol for a population-based ankylosing spondylitis (PAS) cohort in Wales.

Authors:  Mark D Atkinson; Sinead Brophy; Stefan Siebert; Mike B Gravenor; Ceri Phillips; David V Ford; Kerina H Jones; Ronan A Lyons
Journal:  BMC Musculoskelet Disord       Date:  2010-09-01       Impact factor: 2.362

9.  Association study of polymorphisms rs4552569 and rs17095830 and the risk of ankylosing spondylitis in a Taiwanese population.

Authors:  James Cheng-Chung Wei; Yu-Wen Hsu; Kuo-Sheng Hung; Ruey-Hong Wong; Chun-Huang Huang; Yi-Tzu Liu; Yuh-Cherng Guo; Shiro Ikegawa; Wei-Chiao Chang
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

10.  Identification of autoimmune gene signatures in autism.

Authors:  J-Y Jung; I S Kohane; D P Wall
Journal:  Transl Psychiatry       Date:  2011-12-13       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.